Breast Unit Parma

[Breast Unit Parma @breastunitparma]

Today in Parma for the EMPOWERing talks! #BreastUnit #breastcancer @bpellegrino89 @breastunitparma @ChiaraTommasi7 @Matilde___

[Breast Unit Parma @breastunitparma]

#SABCS25: Presentiamo 2 studi su personalizzazione terapia.
1️⃣ Uso selettivo #OncotypeDX in 139/1030 casi. In chi lo fa: 30% chemio. In chi non lo fa (over75/basso grado): solo 7% chemio.
2️⃣ Se PET/RM completa post-neoadiuvante (anche senza pCR): OS 99% a 5 anni.
#BreastCancer

[Matilde Corianò @CorianoMat20668]

Glad to be back again to share our data at the most inspiring BC conference. #sabcs2025
@breastunitparma

[Breast Unit Parma @breastunitparma]

Very useful information for Community Oncologists #IAmAPractisingOncologist

[ESMO - Eur. Oncology @myESMO]

At #ESMOBreast25, the potential benefits of tailoring #chemotherapy use in early ER+/HER2– #BreastCancer based on recurrence risk are reviewed, including the possibility of withholding chemotherapy in some subgroups. Read more in the #ESMODailyReporter
https://t.co/o1eLHtN1U6

[ESMO - Eur. Oncology @myESMO]

#ESMOBreast25: Do not miss the latest research findings in #BreastCancer brought to you by the #ESMOAmbassadors & become part of the conversation. #bcsm
🔗 https://t.co/wnWNKejinf

[Breast Unit Parma @breastunitparma]

Really usefull for your clinical practice!

[ESMO - Eur. Oncology @myESMO]

📣ESMO Living Guidelines on Metastatic Breast Cancer:
👉Just updated with the latest recommendations and algorithms in an interactive format.

🔗https://t.co/kjGexgJ1WZ

#ClinicalPracticeGuideline

[Breast Unit Parma @breastunitparma]

https://t.co/dXV9ChGYuN

[Breast Unit Parma @breastunitparma]

#emiliani do it better! #EMPOWERingtalks #claudiaomarini @elisagasperini @Matilde___ @ChiaraTommasi7 #alessandrolazzarin #michelapalleschi

[Breast Unit Parma @breastunitparma]

Thanks to @antoniomarraMD @GaiaGriguolo

[Breast Unit Parma @breastunitparma]

Today in Parma for the EMPOWERing talks! #BreastUnit #breastcancer @bpellegrino89 @breastunitparma @ChiaraTommasi7 @Matilde___

[ESMO - Eur. Oncology @myESMO]

📣Join us for the upcoming #ESMOGuidelines Webinar!
Dive deep into EGFR-mutated #mNSCLC, resistance mechanisms, and cutting-edge second-line therapies. Expert insights, real-world cases & evidence-based strategies await!

🔗Register now: https://t.co/iy1WR62kD3

[Breast Unit Parma @breastunitparma]

Qst sera le @animesalve_music per @breastunit_parma

[Breast Unit Parma @breastunitparma]

🎶✨ Join us for a special tribute to Fabrizio De André by **Anime Salve** at Teatro di Corcagnano on Feb 8th & 9th! 🎤❤️

Proceeds support breast cancer research at the Breast Unit of Parma.

Call **[phone]** to book your tickets!

#DeAndre #BreastCancerResearch

[Breast Unit Parma @breastunitparma]

🚀 Excited to share the last publication from the MITO group: "Unraveling the complexity of HRD in OvC by combining genomic and functional approaches: translational analyses of MITO16 trial"! Wishing for continued collaboration and success in 2025! 🌟 #OvarianCancer @ESMO_Open

[Benedetta Pellegrino @bpellegrino89]

🚀 Exciting news! 🎉 The #GOIRCTranslationalGroup has just published its first groundbreaking article in @TumoriJ:”Bridging bench to bedside: the evolution and impact of translational research in Oncology”🌟 #Oncology #TranslationalResearch #GOIRC

🔗 https://t.co/TJkPNQKiAE

[Breast Unit Parma @breastunitparma]

@bpellegrino89

[Breast Unit Parma @breastunitparma]

In research we trust #breastcancer #breastcancerresearch @unipr